Related Experiment Video
Updated: Aug 18, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Digoxin visual toxicity with therapeutic blood levels of digoxin
1Neuro-ophthalmology, Anderson Eye and Ear Associates, SC 29627, USA. mjwolin@carol.net
Purpose:
To report two cases of digoxin-related visual disturbances associated with therapeutic blood levels of digoxin.
Methods:
Case reports. One patient reported shimmering lights in the field of vision of both eyes; the second patient had a corrected visual acuity of BE, 20/40 and generalized visual field depression in both eyes. Both patients experienced these symptoms while receiving digoxin.
Results:
Both patients had digoxin blood levels in the therapeutic range (1.7 and 1.0 ng/ml, respectively). Therapeutic levels are 0.5 to 2.0 ng/ml. After discontinuing digoxin, the first patient noted that the shimmering light symptoms resolved, and the second patient had improved visual acuity and visual fields.
Conclusions:
Digoxin-related visual toxicity may be associated with therapeutic blood levels of digoxin. Recognition of this entity may avoid unnecessary testing and frustration.
More Related Videos
Related Concept Videos
Therapeutic Index
Heart Failure Drugs: Inotropic Agents
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Toxicity: Overview
Drug Toxicity: Dose-Dependent Reactions

